for Physicians
for Patients

Research Project

Project Title:

Phase 3 study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients

Project Type:

 Clinical Trial, Enrolment ongoing

Disease group(s):

 Immune glomerulopathies

Project Summary:

 This is a phase 3 study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients.

Lead principal investigator(s):

 Gaetano La Manna, Bologna

Co-investigator(s):

 Olga Baraldi, Bologna

Project Period:

 11/2021   -   11/2050

Sponsors:

 Industry
« Back to research page